Last checked at 
(Adds details on Norwegian cases.)
COPENHAGEN, March 15 (Reuters) - A 60-year old Danish woman
who died of a blood clot after receiving AstraZeneca's COVID-19
vaccine had "highly unusual" symptoms, according to the Danish
Medicines Agency.
The woman had a low number of blood platelets and clots in
small and large vessels, as well as bleeding, it said.
A few similar cases were found in Norway and in the European
Medicines Agency's (EMA) database of drug side effects, Danish
Medicines Agency said.
"It was an unusual course of illness around the death that
made the Danish Medicines Agency react," it said in a statement
late on Sunday.
Norway said on Saturday that three people, all under the age
of 50, who had received the AstraZeneca vaccine were being
treated in hospital for bleeding, blood clots and a low count of
blood platelets, which were labeled "unusual symptoms" by health
authorities.
Denmark, Norway and Iceland said last week they would halt
the introduction of the AstraZeneca vaccine.
European vaccination programmes have been upset in the last
two weeks by reports that recipients of the AstraZeneca
inoculation have suffered blood clots.
The European Medicines Agency has said there is no
indication that the events were caused by the vaccination, a
view that was echoed by the World Health Organization on Friday.
AstraZeneca Plc said on Sunday a review of safety
data of people vaccinated with its COVID-19 vaccine has shown no
evidence of an increased risk of blood clots.
(Reporting by Jacob Gronholt-Pedersen; editing by Catherine
Evans, Larry King)
